Concepedia

Multidisciplinary Approach including Receptor Radionuclide Therapy with 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-OCTREOTIDE) and 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3]-OCTREOTATE) in Ectopic Cushing Syndrome from Ametastatic Gastrinoma: A Promising Proposal

Maria Vittoria Davì, Lisa Bodei, M Ferdeghini, Massimo Falconi, Marco Testoni, Giovanni Paganelli, Cristina Oliani, Vincenzo Lo Cascio, Giuseppe Francia

Endocrine Practice · 2008 · 11 citations · 15 references

DOI

Concepts

References

15

Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health

Ιoannis Ilias, David J. Torpy, Karel Pacák et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 711 citations

, , +17

Radiolabeled Somatostatin Analog [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Dik J. Kwekkeboom, Jaap J.M. Teunissen, Willem H. Bakker et al. · Journal of Clinical Oncology · 2005 · 659 citations · Full text

, , +15

The Ectopic Adrenocorticotropin Syndrome: Clinical Features, Diagnosis, Management, and Long-Term Follow-Up

Andrea M. Isidori, Gregory Kaltsas, Carlotta Pozza et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 521 citations · Full text

, , +17

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

Christian Waldherr, Miklos Pless, Helmut R. Maëcke et al. · PubMed · 2002 · 446 citations

, , +15

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Dik J. Kwekkeboom, Jan Mueller‐Brand, Giovanni Paganelli et al. · PubMed · 2005 · 375 citations · Full text

, , +17